We constructed a Markov model to evaluate the cost-effectiveness of three CHB management scenarios in the Chinese population (aged ≥18 years).9,14,15 The study was conducted from a healthcare provider's perspective and presented according to the Consolidated Health Economic Evaluation Reporting Standards (details in Supplementary Materials).16
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.